

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid biosynthetic process (GO:0006688) | 6.72688524 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.45903336 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75915388 |
| 4 | glycosylceramide metabolic process (GO:0006677) | 4.71150541 |
| 5 | positive regulation of defense response to virus by host (GO:0002230) | 4.59182509 |
| 6 | negative regulation of telomere maintenance (GO:0032205) | 4.55846158 |
| 7 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 4.33660583 |
| 8 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 4.33660583 |
| 9 | UV protection (GO:0009650) | 4.25635017 |
| 10 | nucleobase catabolic process (GO:0046113) | 4.24127662 |
| 11 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 4.18362353 |
| 12 | regulation of telomere maintenance (GO:0032204) | 4.17407482 |
| 13 | hepatocyte apoptotic process (GO:0097284) | 4.16013331 |
| 14 | C4-dicarboxylate transport (GO:0015740) | 4.13840292 |
| 15 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.09875333 |
| 16 | bicarbonate transport (GO:0015701) | 4.03456589 |
| 17 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.91835162 |
| 18 | isotype switching (GO:0045190) | 3.91835162 |
| 19 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.91835162 |
| 20 | neural tube formation (GO:0001841) | 3.91106747 |
| 21 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.86171457 |
| 22 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.86171457 |
| 23 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.84847609 |
| 24 | corticosteroid receptor signaling pathway (GO:0031958) | 3.81509223 |
| 25 | behavioral response to nicotine (GO:0035095) | 3.75192672 |
| 26 | lymphoid progenitor cell differentiation (GO:0002320) | 3.73635425 |
| 27 | negative regulation of B cell proliferation (GO:0030889) | 3.72324242 |
| 28 | rRNA catabolic process (GO:0016075) | 3.71031709 |
| 29 | defense response to protozoan (GO:0042832) | 3.56436444 |
| 30 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.48830125 |
| 31 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.47699804 |
| 32 | ribonucleoprotein complex disassembly (GO:0032988) | 3.43393578 |
| 33 | regulation of intracellular pH (GO:0051453) | 3.43246307 |
| 34 | epithelial cilium movement (GO:0003351) | 3.39969325 |
| 35 | ether lipid metabolic process (GO:0046485) | 3.38608739 |
| 36 | transepithelial transport (GO:0070633) | 3.38463629 |
| 37 | RNA localization (GO:0006403) | 3.35302153 |
| 38 | one-carbon compound transport (GO:0019755) | 3.30825184 |
| 39 | regulation of cellular pH (GO:0030641) | 3.30626325 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.28274632 |
| 41 | negative regulation of type 2 immune response (GO:0002829) | 3.25978543 |
| 42 | ceramide biosynthetic process (GO:0046513) | 3.21134037 |
| 43 | organelle disassembly (GO:1903008) | 3.21020007 |
| 44 | response to misfolded protein (GO:0051788) | 3.15682505 |
| 45 | DNA deamination (GO:0045006) | 3.08650068 |
| 46 | negative regulation of circadian rhythm (GO:0042754) | 3.06155685 |
| 47 | response to protozoan (GO:0001562) | 3.04913450 |
| 48 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.02647118 |
| 49 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.01089112 |
| 50 | GTP biosynthetic process (GO:0006183) | 2.98534919 |
| 51 | mitotic recombination (GO:0006312) | 2.96986817 |
| 52 | regulation of T-helper 1 type immune response (GO:0002825) | 2.95667915 |
| 53 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.93196244 |
| 54 | regulation of memory T cell differentiation (GO:0043380) | 2.91756864 |
| 55 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.90989809 |
| 56 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.90246328 |
| 57 | male meiosis I (GO:0007141) | 2.89502546 |
| 58 | somatic diversification of immunoglobulins (GO:0016445) | 2.89230473 |
| 59 | response to pheromone (GO:0019236) | 2.88895692 |
| 60 | negative regulation of protein autophosphorylation (GO:0031953) | 2.88472127 |
| 61 | cytidine deamination (GO:0009972) | 2.87980970 |
| 62 | cytidine metabolic process (GO:0046087) | 2.87980970 |
| 63 | cytidine catabolic process (GO:0006216) | 2.87980970 |
| 64 | regulation of triglyceride catabolic process (GO:0010896) | 2.87318998 |
| 65 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.85055375 |
| 66 | fucose catabolic process (GO:0019317) | 2.83521941 |
| 67 | L-fucose metabolic process (GO:0042354) | 2.83521941 |
| 68 | L-fucose catabolic process (GO:0042355) | 2.83521941 |
| 69 | single strand break repair (GO:0000012) | 2.82729151 |
| 70 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 2.81255451 |
| 71 | regulation of B cell differentiation (GO:0045577) | 2.80758213 |
| 72 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.80634705 |
| 73 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.78629155 |
| 74 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.78629155 |
| 75 | negative regulation of histone acetylation (GO:0035067) | 2.77328390 |
| 76 | positive regulation of interleukin-12 production (GO:0032735) | 2.77180861 |
| 77 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.76162108 |
| 78 | T cell costimulation (GO:0031295) | 2.75570948 |
| 79 | negative regulation of B cell activation (GO:0050869) | 2.73879424 |
| 80 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.73129015 |
| 81 | lymphocyte costimulation (GO:0031294) | 2.71719970 |
| 82 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.70855080 |
| 83 | negative regulation of mast cell activation (GO:0033004) | 2.67258685 |
| 84 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.64328573 |
| 85 | regulation of isotype switching (GO:0045191) | 2.63805265 |
| 86 | cell wall macromolecule catabolic process (GO:0016998) | 2.62024183 |
| 87 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.61214760 |
| 88 | microtubule depolymerization (GO:0007019) | 2.60726809 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59845016 |
| 90 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.59383184 |
| 91 | cellular protein catabolic process (GO:0044257) | 2.58383473 |
| 92 | DNA integration (GO:0015074) | 2.56052129 |
| 93 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.55787443 |
| 94 | UMP metabolic process (GO:0046049) | 2.55787443 |
| 95 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.55787443 |
| 96 | UMP biosynthetic process (GO:0006222) | 2.55787443 |
| 97 | regulation of DNA endoreduplication (GO:0032875) | 2.55605513 |
| 98 | regulation of calcium-mediated signaling (GO:0050848) | 2.55505056 |
| 99 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.55436404 |
| 100 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.53246227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.18076139 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.03547527 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.72469151 |
| 4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.46517876 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.34651099 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.22945658 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.20989337 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.20230281 |
| 9 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 3.03701715 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.91554987 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75536880 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.60457221 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.58639384 |
| 14 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.51210585 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38070048 |
| 16 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.27054736 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07571238 |
| 18 | TP53_16413492_ChIP-PET_HCT116_Human | 2.05785020 |
| 19 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00613980 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 2.00461784 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.79882049 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.75972174 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74103574 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.72160106 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66169358 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65981612 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63614843 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62641793 |
| 29 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.61912797 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.58528660 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57590779 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57387989 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.57042558 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.56393921 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56228482 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55454342 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55451450 |
| 38 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.54887967 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50238223 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.50080170 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47005986 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46154421 |
| 43 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.39358892 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38581297 |
| 45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.36822444 |
| 46 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.35590741 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33913139 |
| 48 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.33807741 |
| 49 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33068231 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29953029 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27737367 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27435950 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26661227 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26060923 |
| 55 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.24649400 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24410509 |
| 57 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.20290078 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20218058 |
| 59 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19463389 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18395254 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17456463 |
| 62 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15779341 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14423281 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14382411 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13972599 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11998479 |
| 67 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11015617 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09916000 |
| 69 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09559418 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07812364 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07719494 |
| 72 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04865121 |
| 73 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04224221 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04176990 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04176990 |
| 76 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04080262 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03914399 |
| 78 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.03800543 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02142947 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00452206 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00389823 |
| 82 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00257750 |
| 83 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99014121 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97930338 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97930338 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97809248 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97053298 |
| 88 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96019827 |
| 89 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.95421494 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94180186 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93606849 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91873472 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 0.91652353 |
| 94 | GATA3_26560356_Chip-Seq_TH1_Human | 0.91281879 |
| 95 | ERA_21632823_ChIP-Seq_H3396_Human | 0.91265330 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91213104 |
| 97 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.90738215 |
| 98 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.90123463 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89426481 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.88643512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 6.27755158 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.51373809 |
| 3 | MP0008057_abnormal_DNA_replication | 4.47739559 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 3.85407147 |
| 5 | MP0005367_renal/urinary_system_phenotyp | 3.78804203 |
| 6 | MP0000516_abnormal_urinary_system | 3.78804203 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.62319926 |
| 8 | MP0002876_abnormal_thyroid_physiology | 3.35863807 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.97530369 |
| 10 | MP0002090_abnormal_vision | 2.46125348 |
| 11 | MP0004043_abnormal_pH_regulation | 2.26572854 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.04598516 |
| 13 | MP0005671_abnormal_response_to | 2.02423679 |
| 14 | MP0006082_CNS_inflammation | 1.97601045 |
| 15 | MP0005365_abnormal_bile_salt | 1.84015198 |
| 16 | MP0001545_abnormal_hematopoietic_system | 1.81115217 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 1.81115217 |
| 18 | MP0005670_abnormal_white_adipose | 1.79187785 |
| 19 | MP0008872_abnormal_physiological_respon | 1.66424245 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 1.64724617 |
| 21 | MP0002102_abnormal_ear_morphology | 1.64143671 |
| 22 | MP0000685_abnormal_immune_system | 1.63618837 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.60860612 |
| 24 | MP0001800_abnormal_humoral_immune | 1.57557506 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.56851036 |
| 26 | MP0008058_abnormal_DNA_repair | 1.54195313 |
| 27 | MP0002396_abnormal_hematopoietic_system | 1.50941480 |
| 28 | MP0009785_altered_susceptibility_to | 1.48900239 |
| 29 | MP0005253_abnormal_eye_physiology | 1.47590759 |
| 30 | MP0005266_abnormal_metabolism | 1.43091386 |
| 31 | MP0002723_abnormal_immune_serum | 1.34207271 |
| 32 | MP0003646_muscle_fatigue | 1.34162201 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.29526441 |
| 34 | MP0001542_abnormal_bone_strength | 1.28705859 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.28608694 |
| 36 | MP0000647_abnormal_sebaceous_gland | 1.25551201 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18809300 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.10419570 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.10399071 |
| 40 | MP0009745_abnormal_behavioral_response | 1.09801458 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.09288454 |
| 42 | MP0001919_abnormal_reproductive_system | 1.05759903 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.05108684 |
| 44 | MP0008877_abnormal_DNA_methylation | 1.02259928 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.02112171 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.01779829 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.97712840 |
| 48 | MP0002398_abnormal_bone_marrow | 0.97368141 |
| 49 | MP0001819_abnormal_immune_cell | 0.96801816 |
| 50 | MP0005025_abnormal_response_to | 0.96263148 |
| 51 | MP0001501_abnormal_sleep_pattern | 0.94302380 |
| 52 | MP0005387_immune_system_phenotype | 0.93987466 |
| 53 | MP0001790_abnormal_immune_system | 0.93987466 |
| 54 | MP0000716_abnormal_immune_system | 0.92765850 |
| 55 | MP0005410_abnormal_fertilization | 0.92614334 |
| 56 | MP0002405_respiratory_system_inflammati | 0.92129001 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 0.89383045 |
| 58 | MP0003693_abnormal_embryo_hatching | 0.88162303 |
| 59 | MP0002429_abnormal_blood_cell | 0.86578766 |
| 60 | MP0003763_abnormal_thymus_physiology | 0.85812950 |
| 61 | MP0002160_abnormal_reproductive_system | 0.84492411 |
| 62 | MP0010155_abnormal_intestine_physiology | 0.84286712 |
| 63 | MP0000372_irregular_coat_pigmentation | 0.84123683 |
| 64 | MP0005389_reproductive_system_phenotype | 0.81430867 |
| 65 | MP0009764_decreased_sensitivity_to | 0.79015641 |
| 66 | MP0003880_abnormal_central_pattern | 0.78853148 |
| 67 | MP0005535_abnormal_body_temperature | 0.78846777 |
| 68 | MP0001853_heart_inflammation | 0.77919927 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.77605314 |
| 70 | MP0002419_abnormal_innate_immunity | 0.77288490 |
| 71 | MP0003011_delayed_dark_adaptation | 0.76718035 |
| 72 | MP0004147_increased_porphyrin_level | 0.76140592 |
| 73 | MP0004142_abnormal_muscle_tone | 0.76072019 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.73931792 |
| 75 | MP0004381_abnormal_hair_follicle | 0.73166377 |
| 76 | MP0003890_abnormal_embryonic-extraembry | 0.72054419 |
| 77 | MP0003252_abnormal_bile_duct | 0.71162559 |
| 78 | MP0002163_abnormal_gland_morphology | 0.70709709 |
| 79 | MP0002006_tumorigenesis | 0.69527261 |
| 80 | MP0009697_abnormal_copulation | 0.68357604 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.68128794 |
| 82 | MP0002254_reproductive_system_inflammat | 0.68101086 |
| 83 | MP0001486_abnormal_startle_reflex | 0.67162680 |
| 84 | MP0003866_abnormal_defecation | 0.66133868 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 0.65865742 |
| 86 | MP0001188_hyperpigmentation | 0.65425987 |
| 87 | MP0000604_amyloidosis | 0.65082493 |
| 88 | MP0000490_abnormal_crypts_of | 0.64856908 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.64562082 |
| 90 | MP0005310_abnormal_salivary_gland | 0.64177680 |
| 91 | MP0002722_abnormal_immune_system | 0.62702862 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.61521899 |
| 93 | MP0004883_abnormal_blood_vessel | 0.61029322 |
| 94 | MP0003786_premature_aging | 0.58558893 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.58479797 |
| 96 | MP0004084_abnormal_cardiac_muscle | 0.58111689 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.57743590 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.56937782 |
| 99 | MP0003943_abnormal_hepatobiliary_system | 0.56496073 |
| 100 | MP0005360_urolithiasis | 0.56005909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Concave nail (HP:0001598) | 5.48119145 |
| 2 | Stomatitis (HP:0010280) | 5.15180666 |
| 3 | Metaphyseal dysplasia (HP:0100255) | 4.98747513 |
| 4 | Poor eye contact (HP:0000817) | 4.05793722 |
| 5 | Pancreatic cysts (HP:0001737) | 3.75279957 |
| 6 | Bilateral microphthalmos (HP:0007633) | 3.57542243 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.48141619 |
| 8 | Gastrointestinal infarctions (HP:0005244) | 3.34501147 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.32058626 |
| 10 | True hermaphroditism (HP:0010459) | 3.28732790 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.24986749 |
| 12 | Type 2 muscle fiber atrophy (HP:0003554) | 3.23245514 |
| 13 | Follicular hyperkeratosis (HP:0007502) | 3.17065082 |
| 14 | Abnormality of T cell physiology (HP:0011840) | 3.11590779 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00656614 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00656614 |
| 17 | Chronic hepatic failure (HP:0100626) | 2.96963120 |
| 18 | Abnormality of the prostate (HP:0008775) | 2.94360405 |
| 19 | Multiple enchondromatosis (HP:0005701) | 2.92762468 |
| 20 | Acute lymphatic leukemia (HP:0006721) | 2.92573097 |
| 21 | Hyperventilation (HP:0002883) | 2.89099602 |
| 22 | Impaired social interactions (HP:0000735) | 2.88280929 |
| 23 | Abnormal social behavior (HP:0012433) | 2.88280929 |
| 24 | Agammaglobulinemia (HP:0004432) | 2.87312575 |
| 25 | Cystic liver disease (HP:0006706) | 2.72616142 |
| 26 | Poor head control (HP:0002421) | 2.61941479 |
| 27 | Blepharitis (HP:0000498) | 2.61766337 |
| 28 | Tubular atrophy (HP:0000092) | 2.60855294 |
| 29 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.58836227 |
| 30 | Neuroendocrine neoplasm (HP:0100634) | 2.57736073 |
| 31 | Muscle fiber atrophy (HP:0100295) | 2.53830229 |
| 32 | Polydipsia (HP:0001959) | 2.52971838 |
| 33 | Abnormal drinking behavior (HP:0030082) | 2.52971838 |
| 34 | Abnormality of nail color (HP:0100643) | 2.52762722 |
| 35 | Pachygyria (HP:0001302) | 2.47484137 |
| 36 | Occipital encephalocele (HP:0002085) | 2.46747694 |
| 37 | Focal motor seizures (HP:0011153) | 2.45705702 |
| 38 | Chest pain (HP:0100749) | 2.45688706 |
| 39 | Poor speech (HP:0002465) | 2.43230191 |
| 40 | Neonatal respiratory distress (HP:0002643) | 2.41999789 |
| 41 | Acute hepatic failure (HP:0006554) | 2.41383716 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.39221579 |
| 43 | Patellar aplasia (HP:0006443) | 2.36129389 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.35101019 |
| 45 | Lissencephaly (HP:0001339) | 2.34602393 |
| 46 | Ureteral obstruction (HP:0006000) | 2.32922653 |
| 47 | Recurrent viral infections (HP:0004429) | 2.31398253 |
| 48 | Recurrent skin infections (HP:0001581) | 2.30505382 |
| 49 | Bundle branch block (HP:0011710) | 2.29499032 |
| 50 | Short middle phalanx of the 5th finger (HP:0004220) | 2.28709824 |
| 51 | Severe muscular hypotonia (HP:0006829) | 2.28001798 |
| 52 | Ureteral stenosis (HP:0000071) | 2.23162202 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21757969 |
| 54 | Increased corneal curvature (HP:0100692) | 2.18661486 |
| 55 | Keratoconus (HP:0000563) | 2.18661486 |
| 56 | Tachypnea (HP:0002789) | 2.18479888 |
| 57 | Gangrene (HP:0100758) | 2.16558513 |
| 58 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.16529640 |
| 59 | Tetraplegia (HP:0002445) | 2.16045461 |
| 60 | Type II lissencephaly (HP:0007260) | 2.14497063 |
| 61 | Acute myeloid leukemia (HP:0004808) | 2.12798970 |
| 62 | Decreased circulating renin level (HP:0003351) | 2.09840511 |
| 63 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.09348601 |
| 64 | Gaze-evoked nystagmus (HP:0000640) | 2.08478364 |
| 65 | Cerebellar dysplasia (HP:0007033) | 2.07083918 |
| 66 | Meningitis (HP:0001287) | 2.05529499 |
| 67 | Abnormality of T cells (HP:0002843) | 2.03838941 |
| 68 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.00789057 |
| 69 | Hemoptysis (HP:0002105) | 2.00449951 |
| 70 | Vasculitis (HP:0002633) | 1.98539498 |
| 71 | Asplenia (HP:0001746) | 1.98334801 |
| 72 | Nephronophthisis (HP:0000090) | 1.98253875 |
| 73 | Abnormality of the vocal cords (HP:0008777) | 1.94825553 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 1.93090075 |
| 75 | Anencephaly (HP:0002323) | 1.92125279 |
| 76 | Cleft eyelid (HP:0000625) | 1.90578107 |
| 77 | IgG deficiency (HP:0004315) | 1.90171779 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 1.88292866 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 1.87766118 |
| 80 | Tinnitus (HP:0000360) | 1.87663480 |
| 81 | Abnormality of the pleura (HP:0002103) | 1.87565698 |
| 82 | Clubbing of toes (HP:0100760) | 1.87482121 |
| 83 | Sclerocornea (HP:0000647) | 1.86792832 |
| 84 | Large eyes (HP:0001090) | 1.86729012 |
| 85 | Polyuria (HP:0000103) | 1.85799235 |
| 86 | Chronic diarrhea (HP:0002028) | 1.85438303 |
| 87 | Focal seizures (HP:0007359) | 1.85230535 |
| 88 | Abnormality of the preputium (HP:0100587) | 1.85026258 |
| 89 | Abnormality of the pubic bones (HP:0003172) | 1.83971451 |
| 90 | Congenital hepatic fibrosis (HP:0002612) | 1.83842565 |
| 91 | Adenoma sebaceum (HP:0009720) | 1.82507799 |
| 92 | Angiofibromas (HP:0010615) | 1.82507799 |
| 93 | Pulmonary infiltrates (HP:0002113) | 1.81455522 |
| 94 | Nonprogressive disorder (HP:0003680) | 1.80460015 |
| 95 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78879157 |
| 96 | Increased IgM level (HP:0003496) | 1.78123661 |
| 97 | Mediastinal lymphadenopathy (HP:0100721) | 1.75270477 |
| 98 | Disinhibition (HP:0000734) | 1.75261405 |
| 99 | Spondylolisthesis (HP:0003302) | 1.74694618 |
| 100 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74443362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FLT3 | 4.97843870 |
| 2 | ADRBK2 | 3.61715359 |
| 3 | CSF1R | 3.37187695 |
| 4 | ZAK | 3.06883420 |
| 5 | PINK1 | 2.99143039 |
| 6 | GRK7 | 2.89510581 |
| 7 | KIT | 2.83151725 |
| 8 | RIPK4 | 2.74427891 |
| 9 | TAOK3 | 2.74158123 |
| 10 | PIK3CG | 2.47054141 |
| 11 | MAP4K2 | 2.45185774 |
| 12 | BMPR2 | 2.31968853 |
| 13 | MAP2K3 | 2.21486026 |
| 14 | FRK | 2.18398537 |
| 15 | SIK2 | 2.10570146 |
| 16 | RPS6KA4 | 2.06121224 |
| 17 | TYK2 | 2.03035045 |
| 18 | MKNK2 | 2.01431507 |
| 19 | BRD4 | 2.00950593 |
| 20 | SIK3 | 1.70020613 |
| 21 | MAP3K3 | 1.62530495 |
| 22 | GRK1 | 1.48471740 |
| 23 | CDK19 | 1.42509949 |
| 24 | PRKCE | 1.40483465 |
| 25 | EPHB1 | 1.36565172 |
| 26 | RIPK1 | 1.33615275 |
| 27 | PTK2B | 1.15339245 |
| 28 | IKBKB | 1.13960186 |
| 29 | MKNK1 | 1.11882936 |
| 30 | WNK3 | 1.10376409 |
| 31 | RPS6KA1 | 1.05975353 |
| 32 | TXK | 1.01532553 |
| 33 | MAP3K4 | 1.00908215 |
| 34 | JAK1 | 0.98242245 |
| 35 | OXSR1 | 0.96637618 |
| 36 | MARK3 | 0.95259474 |
| 37 | MARK1 | 0.94255242 |
| 38 | MAP4K1 | 0.91328793 |
| 39 | LYN | 0.88865355 |
| 40 | STK3 | 0.81747831 |
| 41 | LCK | 0.75330169 |
| 42 | SGK3 | 0.75065511 |
| 43 | CAMK4 | 0.74750578 |
| 44 | PAK3 | 0.74603744 |
| 45 | WNK4 | 0.73991554 |
| 46 | CLK1 | 0.73337742 |
| 47 | EIF2AK3 | 0.72819301 |
| 48 | MAP2K4 | 0.72370112 |
| 49 | PRKCQ | 0.72184446 |
| 50 | CAMKK2 | 0.70956234 |
| 51 | SGK2 | 0.70408158 |
| 52 | MAPK13 | 0.68859632 |
| 53 | TIE1 | 0.67499250 |
| 54 | SYK | 0.67386136 |
| 55 | DAPK2 | 0.66875597 |
| 56 | STK39 | 0.66728020 |
| 57 | MAP2K7 | 0.64079788 |
| 58 | SGK494 | 0.63376875 |
| 59 | SGK223 | 0.63376875 |
| 60 | AKT3 | 0.62301697 |
| 61 | CDK7 | 0.61354854 |
| 62 | MATK | 0.60178028 |
| 63 | CHEK1 | 0.60139429 |
| 64 | TGFBR2 | 0.59495055 |
| 65 | RPS6KB2 | 0.59400436 |
| 66 | CAMK1 | 0.58061011 |
| 67 | MAP3K6 | 0.57562470 |
| 68 | VRK1 | 0.56830265 |
| 69 | MAPKAPK3 | 0.56765521 |
| 70 | STK11 | 0.56429667 |
| 71 | PRKAA1 | 0.52865937 |
| 72 | SCYL2 | 0.50582761 |
| 73 | DYRK2 | 0.50547775 |
| 74 | CSNK2A2 | 0.48853719 |
| 75 | ERBB3 | 0.45686604 |
| 76 | BCKDK | 0.44960163 |
| 77 | EPHA4 | 0.44440904 |
| 78 | CDK8 | 0.44361996 |
| 79 | IGF1R | 0.44120463 |
| 80 | PRKACB | 0.43541183 |
| 81 | RPS6KA5 | 0.43039999 |
| 82 | ABL1 | 0.41952853 |
| 83 | CSNK1G2 | 0.41182723 |
| 84 | PRKCD | 0.40836335 |
| 85 | PDK1 | 0.40780375 |
| 86 | CSNK1G3 | 0.40092810 |
| 87 | ADRBK1 | 0.39791588 |
| 88 | CHEK2 | 0.37325344 |
| 89 | YES1 | 0.37046386 |
| 90 | MAP3K5 | 0.35724163 |
| 91 | CSNK1A1 | 0.35403370 |
| 92 | TBK1 | 0.34261195 |
| 93 | FYN | 0.32931594 |
| 94 | PRKCA | 0.32614089 |
| 95 | INSRR | 0.31512960 |
| 96 | PIM1 | 0.30312506 |
| 97 | CDC7 | 0.29766894 |
| 98 | CDK3 | 0.29487021 |
| 99 | JAK3 | 0.28468601 |
| 100 | KDR | 0.28207530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 5.33898823 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.24989949 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.94028456 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.78303958 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.62556475 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.33192868 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.74883984 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.55937332 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.30547081 |
| 10 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.13735974 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06596131 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.93326111 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92168045 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.91331551 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.68571628 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.66507462 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62228907 |
| 18 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.56760695 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53964038 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51231480 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45807227 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38638059 |
| 23 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.37832350 |
| 24 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.35155924 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34654962 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.27460827 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27393031 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.23831859 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18473432 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17970031 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14573631 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.11887034 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.11011054 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09523209 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09479577 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01722686 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95573666 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 0.93936560 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 0.93277598 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90951518 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90491288 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88433253 |
| 43 | Mismatch repair_Homo sapiens_hsa03430 | 0.85192544 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83490529 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83405060 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82643723 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 0.81779764 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80521273 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75392974 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.72194577 |
| 51 | Alcoholism_Homo sapiens_hsa05034 | 0.71468524 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70995602 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69308033 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69246587 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67669999 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67471365 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65625539 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64919064 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62248223 |
| 60 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.60362482 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57932077 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55570379 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55409290 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.55352498 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 0.54667710 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52707966 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.50878676 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50773697 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50599652 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.47847813 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45844083 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44825773 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44021136 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.42384382 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.41489926 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39720881 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39407299 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.38068828 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35606834 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34603236 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34387960 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.33936394 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33196529 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31674461 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31633902 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31564780 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30278518 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29556813 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29091307 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28815902 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.27872626 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26584369 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.24714268 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.21405771 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20888132 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.20773736 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.20194965 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19244535 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18173555 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17027565 |

